SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/250449"
 

Search: onr:"swepub:oai:gup.ub.gu.se/250449" > Interplay between g...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Interplay between gut microbiota, its metabolites and human metabolism: Dissecting cause from consequence

Hartstra, A. V. (author)
Nieuwdorp, Max (author)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
Herrema, H. (author)
 (creator_code:org_t)
Elsevier BV, 2016
2016
English.
In: Trends in Food Science & Technology. - : Elsevier BV. - 0924-2244. ; 57, s. 233-243
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Alterations in gut microbiota composition and bacterial metabolites have been increasingly recognized to affect host metabolism and are at the basis of metabolic diseases such as obesity and type 2 diabetes (DM2). Intestinal enteroendocrine cells (EEC's) sense gut luminal content and accordingly secrete hormones that modulate glucose and lipid metabolism and affect satiety. It has become evident that microbial metabolic products significantly affect EEC function. Scope and approach: In this review, we will discuss current insights in the role of the gut microbiota and its metabolites in development of obesity and DM2 and elaborate on interventions that modulate EEC action. Key findings and conclusions: Studies including fecal transplantation and Roux-en-Y gastric bypass (RYGB) in humans and animal models suggest that the gut microbiota and its metabolites causally contribute to development of obesity and DM2. Emerging evidence suggests that the gut microbiota and its metabolites can modulate secretion of EEC hormones that regulate appetite and insulin secretion. Dispersed intestinal expression and low abundance make EEC's difficult to study. Since current intestinal sampling methods in humans are mostly limited to the colon, this leaves a large part of EEC function understudied. It would therefore be relevant to develop means to extend sampling methods throughout to entire GI tract. (C) 2016 Elsevier Ltd. All rights reserved.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

Microbiota
Metabolic disease
Enteroendocrine cells
Fecal transplantation
Roux-en-Y gastric bypass
glucagon-like peptide-1
y gastric bypass
high-fat-diet
protein-coupled receptor
vertical sleeve gastrectomy
induced-weight-loss
see vol. 65
insulin-resistance
induced obesity
glucose-homeostasis

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Hartstra, A. V.
Nieuwdorp, Max
Herrema, H.
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
Articles in the publication
Trends in Food S ...
By the university
University of Gothenburg

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view